Tag Archives: rituximab

Rituximab impedes natural killer cell function in CFS/ME patients

Research abstract: Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation by Natalie Eaton, Hélène Cabanas, Cassandra Balinas, Anne Klein, Donald Staines and Sonya Marshall-Gradisnik in BMC Pharmacology and Toxicology 2018 19:12 [Published: … Continue reading

Posted in News | Tagged , , , , , , , , , , | Comments Off on Rituximab impedes natural killer cell function in CFS/ME patients

UK trial of rituximab for ME is no longer practical or even possible to perform

Invest in ME blog post, 11 Feb 2018:  Statement following preliminary Phase III Rituximab clinical trial results from Norway Following the preliminary results which Professor Olav Mella recently publicly released from the Phase III multi-centre double-blinded placebo-controlled Rituximab Clinical Trial (see statement 21st November 2017) … Continue reading

Posted in News | Tagged , | Comments Off on UK trial of rituximab for ME is no longer practical or even possible to perform

Norwegian rituximab trial reports negative results

The Norwegian Rituximab trial reports negative results ahead of the publication of the full results. Attempts are now under way to determine the best way forward in understanding what has been learned and how to find out which patients may still benefit from … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on Norwegian rituximab trial reports negative results

Norwegian Rituximab studies update

Helse Bergen blog post, 29 Sep 29017: RituxME B-lymphocyte depletion using the anti-CD20 antibody rituximab (Mabthera®) in Myalgic Encephalopathy/Chronic Fatigue Syndrome (“RituxME”) ​RituxME is a multicentre study conducted in five study centres in Norway: the Oncology Department at Haukeland University … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Norwegian Rituximab studies update

The evolution of a ME/CFS researcher? CBT proponent calls for more Herpesvirus research

Simmaron Research blog post, by Cort Johnson, 19 June 2017: The Evolution of a Chronic Fatigue Syndrome (ME/CFS) Researcher? CBT Proponent Calls for More Herpesvirus Research At times Dr. Wyller of Oslo University has seemed more like a Norwegian version … Continue reading

Posted in News | Tagged , , , , , | Comments Off on The evolution of a ME/CFS researcher? CBT proponent calls for more Herpesvirus research

UK Rituximab trial collaboration between Norway & UK featured on BBC

BBC Look East video clip, 26 January 2017: Research in Norwich could offer ME/CFS breakthrough  Researchers in Norwich are teaming up with researchers from Norway to collaborate on ME/CFS research. The researchers say they believe that ME is reversible, and … Continue reading

Posted in News | Tagged , , , , , , , | Comments Off on UK Rituximab trial collaboration between Norway & UK featured on BBC

The RituxME & CycloME studies – video of Dr Oystein Fluge talk

Video posted on the RME Sverige You Tube channel, 19 Nov 2016: The RituxME and CycloME studies – Ongoing Clinical Research in the ME/CFS Research Group, by Öystein Fluge, MD, Dep. Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norge … Continue reading

Posted in News | Tagged , , , , | Comments Off on The RituxME & CycloME studies – video of Dr Oystein Fluge talk

Mella finds hypometabolic state in ME/CFS

Health rising blog post, by Cort Johnson, 15 October 2016: Another Hypometabolic Signature Found Fluge and Mella are best known for their Rituximab work, but just last week Mella reported that they’d found a hypometabolic state in ME/CFS as well. … Continue reading

Posted in News | Tagged , , , , , , , , , | Comments Off on Mella finds hypometabolic state in ME/CFS

New rituximab trial results from Norway

Research abstract: Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS) is a disease of unknown etiology. We have previously suggested clinical benefit from B-cell depletion using the monoclonal anti-CD20 antibody rituximab in a randomized and placebo-controlled study. Prolonged responses were then demonstrated in … Continue reading

Posted in News | Tagged , , , , , | Comments Off on New rituximab trial results from Norway

Unexpected findings & promoting monocausal claims, a cautionary tale

Article abstract: Stories of serendipitous discoveries in medicine incorrectly imply that the path from an unexpected observation to major discovery is straightforward or guaranteed. In this paper, I examine a case from the field of research about chronic fatigue syndrome (CFS). In Norway, … Continue reading

Posted in News | Tagged , , , , | Comments Off on Unexpected findings & promoting monocausal claims, a cautionary tale